tranexamic acid has been researched along with Type 3 Von Willebrand's Disease in 3 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saccullo, G | 1 |
| Makris, M | 1 |
| Boama, V | 1 |
| Haynes, S | 1 |
| Martín-Salces, M | 1 |
| Jiménez-Yuste, V | 1 |
| Álvarez-Román, MT | 1 |
| Rivas-Pollmar, I | 1 |
| Rodríguez de la Rúa, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Emicizumab for Severe VON Willebrand Disease (VWD) and VWD/Hemophilia A[NCT05500807] | Phase 1 | 40 participants (Anticipated) | Interventional | 2022-11-01 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for tranexamic acid and Type 3 Von Willebrand's Disease
| Article | Year |
|---|---|
Prophylaxis in von Willebrand Disease: Coming of Age?
Topics: Deamino Arginine Vasopressin; Factor VIII; Humans; Tranexamic Acid; von Willebrand Disease, Type 1; | 2016 |
2 other studies available for tranexamic acid and Type 3 Von Willebrand's Disease
| Article | Year |
|---|---|
Conservative management of a haemorrhagic adnexal cyst in a patient with Type 3 von Willebrand Disease.
Topics: Abdominal Pain; Adult; Antifibrinolytic Agents; Blood Component Transfusion; Coagulants; Factor VIII | 2011 |
Management of delivery with FVIII/VWF concentrates in a pregnant woman with type 3 von Willebrand disease and alloantibodies.
Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Cesarean Section; Factor VIII; Female; Humans; In | 2012 |